Intensive induction chemotherapy vs hypomethylating agents + venetoclax (HMA/VEN) in NPM1-mutant newly diagnosed acute myeloid leukemia (AML) - A multicenter cohort study Meeting Abstract
| Authors: | Bewersdorf, J. P.; Shimony, S.; Shallis, R. M.; Liu, Y. W.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A. D.; Stein, E. M.; Marcucci, G.; Lindsley, C.; Chen, E. C.; Ramos, J.; Stein, A. S.; DeAngelo, D. J.; Neuberg, D. S.; Stone, R. M.; Ball, B. J.; Stahl, M. |
| Abstract Title: | Intensive induction chemotherapy vs hypomethylating agents + venetoclax (HMA/VEN) in NPM1-mutant newly diagnosed acute myeloid leukemia (AML) - A multicenter cohort study |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 2964 |
| Language: | English |
| ACCESSION: | WOS:001159740302073 |
| DOI: | 10.1182/blood-2023-174285 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
